Erik Skibsted
2Patents
2h-index
4Co-inventors
33Inventor score
Filing activity: Jun 19, 2013 → Apr 20, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9993430B2 | Tablet formulation comprising semaglutide and a delivery agent | Human Necessities | 14 | Active |
| US11033499B2 | Tablet formulation comprising a GLP-1 peptide and a delivery agent | Human Necessities | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.